Evidence map›Paper›PMID 42361012›Full record

ArticlePloS one2026

Integrated NEK7-inflammasome and platelet transcriptomic signature generates mechanistic hypotheses in heart failure.

Zelan Wu, Zhisheng Zheng, Yongkang Li, Botao Li, Shiyu Pi, Daiqin Wu, Zhangrong Chen, Xia Li, Wei Li, Fangjie Dai

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zelan WuDepartment of Cardiovascular Medicine, the Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.ORCID https://orcid.org/0009-0004-3254-6144
Zhisheng ZhengDepartment of Cardiovascular Medicine, the Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
Yongkang LiDepartment of Cardiovascular Medicine, the Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
Botao LiDepartment of Cardiovascular Medicine, the Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
Shiyu PiDepartment of Cardiovascular Medicine, the Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
Daiqin WuDepartment of Cardiovascular Medicine, the Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
Zhangrong ChenDepartment of Cardiovascular Medicine, the Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
Xia LiGuizhou Precision Medicine Institute, the Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
Wei LiDepartment of Cardiovascular Medicine, the Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
Fangjie DaiDepartment of Cardiovascular Medicine, the Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.ORCID https://orcid.org/0000-0003-2652-9423

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe relationship between NEK7-NLRP3 inflammasome activation and elevated platelet activity in the progression of heart failure (HF) is not well understood. Additionally, a comprehensive gene network linking these processes to cardiac fibrosis has not been established. Our study aimed to explore the transcriptomic associations between NEK7-inflammasome, platelet activation and cardiac fibrosis in heart failure (HF), and to generate pathogenic hypotheses.

methodsWe integrated bulk RNA-Seq (GSE116250, GSE57338) and scRNA-Seq (GSE183852) data from human HF samples. Through differential expression analysis, WGCNA, and machine learning techniques (LASSO and SVM-RFE), we identified key genes. A candidate diagnostic nomogram was subsequently developed and internally validated. We also conducted functional enrichment and immune infiltration analyses, and molecular docking studies. Key findings were explored in an angiotensin II-induced murine HF model using quantitative PCR.

resultsWe identified a novel four-gene signature, TIMP2, COL16A1, MDK, and ISLR, that shows co-expression patterns with NEK7 and platelet‑activation‑related gene sets. These genes were significantly upregulated in human HF tissues and showed similar expression trends in murine hearts, although ISLR exhibited a non-significant increase. A preliminary discrimination model based on these genes showed preliminary discriminatory efficacy in the training cohort (AUC = 0.993), however, this model requires further validation in prospective, multi-center cohorts before any clinical application can be considered. Functional enrichment analysis indicated their synergistic involvement in the TGF-β signaling pathway. Immune profiling underscored a correlation with CD56dim natural killer cell infiltration, identifying fibroblasts as the primary expressors of these genes. Pseudotime trajectory analysis illustrated dynamic expression patterns during fibroblast activation, and potential therapeutic compounds, such as β-Heparin and WZ4002, were predicted via molecular docking.

conclusionThis study introduces a novel fibro-inflammatory gene module linked to NEK7-mediated inflammation, platelet activation, and TGF-β signaling in HF. These findings generate integrated mechanistic hypotheses for HF pathogenesis and provide a foundation for subsequent diagnostic and mechanistic explorations.

Indexed as

Blood PlateletsHeart FailureInflammasomesNIMA-Related KinasesTranscriptomeAnimalsFemaleGene Expression ProfilingHumansMaleMiceMolecular Docking SimulationPlatelet ActivationInflammasomesNEK7 protein, humanNIMA-Related Kinases

Identifiers

PMID42361012
PMCPMC13308797

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.